Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab

Bone Marrow Transplantation

Volumn 29, Issue 10, 2002, Pages 871-872

  Hongeng, S ^a   Tardtong, P ^a   Worapongpaiboon, S ^a   Ungkanont, A ^a   Jootar, S ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Autoimmune haemolytic anaemia; Rituximab; Unrelated bone marrow transplantation

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; ERYTHROPOIETIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; RITUXIMAB; THYMOCYTE ANTIBODY; VINCRISTINE; MONOCLONAL ANTIBODY;

ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD SMEAR; BLOOD TRANSFUSION; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; CASE REPORT; CLINICAL FEATURE; COOMBS TEST; HUMAN; MALE; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; REFRACTORY ANEMIA; SIDE EFFECT; T LYMPHOCYTE; THALASSEMIA MAJOR; TREATMENT OUTCOME; ALLOTRANSPLANTATION; BETA THALASSEMIA; BLOOD;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANEMIA, REFRACTORY; ANTIBODIES, MONOCLONAL; BETA-THALASSEMIA; BONE MARROW TRANSPLANTATION; CASE REPORT; CHILD, PRESCHOOL; HUMAN; MALE; TRANSPLANTATION, HOMOLOGOUS; HUMANS;

EID: 0035998368     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703551     Document Type: Article

References (5)

1. Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation
2. Treatment of childhood autoimmune haemolytic anaemia with rituximab
3. Treatment of refractory autoimmune haemolytic anaemia with anti-CD20 (rituximab)
4. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four dose treatment program
5. Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated pure red cell aplasia and hemolytic anemia